Can metoprolol be crushed safely. How does the formulation affect crushability. What are the risks of crushing extended-release metoprolol. When is it appropriate to split metoprolol tablets. How should metoprolol be properly administered in patients with feeding tubes.

Understanding Metoprolol: Two Distinct Formulations

Metoprolol, a widely prescribed beta-blocker, comes in two primary formulations: metoprolol tartrate and metoprolol succinate. Each form has unique properties that directly impact how they can be administered.

Metoprolol Tartrate

Metoprolol tartrate, marketed under the brand name Lopressor, is an immediate-release formulation. This means the medication is designed to release its active ingredient quickly after ingestion.

Metoprolol Succinate

Metoprolol succinate, known by the brand name Toprol XL, is an extended-release formulation. This version is engineered to release the medication slowly over time, providing a more consistent blood level throughout the day.

The Crushability Factor: Which Form Can Be Crushed?

The ability to crush a medication can be crucial for patients who have difficulty swallowing pills or require alternative administration methods. However, not all medications can be safely crushed.

• Metoprolol tartrate (Lopressor) can be safely crushed without altering its effectiveness.
• Metoprolol succinate (Toprol XL) should not be crushed as it would compromise its extended-release mechanism.

Why can’t metoprolol succinate be crushed? Crushing extended-release formulations like metoprolol succinate can cause a rapid release of the entire dose, potentially leading to adverse effects or reduced efficacy over time.

The Unique Case of Metoprolol Succinate Splitting

Interestingly, while metoprolol succinate cannot be crushed, it can be split. This characteristic sets it apart from many other extended-release medications.

How is splitting metoprolol succinate possible? The tablets contain numerous small controlled-release pellets evenly distributed throughout. These pellets remain intact when the tablet is split, preserving the extended-release mechanism.

The Science Behind Metoprolol Succinate’s Design

Each metoprolol succinate tablet houses multiple controlled-release pellets. These pellets act as individual delivery devices, ensuring a consistent release of medication over time. This unique structure allows for tablet splitting without compromising the drug’s extended-release properties.

Proper Administration Techniques for Metoprolol

Administering metoprolol correctly is crucial for ensuring its effectiveness and safety. Here are some guidelines for proper use:

1. For metoprolol tartrate:
   • Can be taken with or without food
   • May be crushed if necessary
   • Should be taken at the same time(s) each day
2. For metoprolol succinate:
   • Should be taken with or right after a meal
   • Can be split if needed, but never crushed
   • Must be swallowed whole or as split halves
   • Should be taken once daily, preferably in the morning

Metoprolol Administration in Special Populations

Certain patient populations may require special considerations when it comes to metoprolol administration.

Patients with Enteral Feeding Tubes

For patients with enteral feeding tubes, medication administration can be challenging. How should metoprolol be given in these cases?

• Metoprolol tartrate can be crushed and administered through a feeding tube.
• Metoprolol succinate is not suitable for tube administration due to its extended-release formulation.
• In cases where metoprolol succinate is prescribed, consult with a pharmacist about alternative formulations or medications.

Patients with Swallowing Difficulties

For patients who have trouble swallowing pills, consider these options:

• Use metoprolol tartrate, which can be crushed and mixed with food or liquid.
• Explore liquid formulations of metoprolol, which may be available or can be compounded by a pharmacy.
• Consider switching to metoprolol succinate, which can be split (but not crushed) if a lower dose is needed.

Risks and Precautions When Altering Metoprolol Formulations

Altering medication formulations can have significant implications for patient safety and drug efficacy. What are the potential risks associated with improperly crushing or splitting metoprolol?

Risks of Crushing Extended-Release Metoprolol

• Dose dumping: Rapid release of the entire dose, potentially leading to adverse effects
• Reduced efficacy: The extended-release mechanism is destroyed, altering the drug’s intended pharmacokinetics
• Inconsistent blood levels: May result in fluctuating blood pressure control

Precautions When Splitting Metoprolol Succinate

• Use a pill splitter for accurate halving
• Split only along the score line
• Take both halves within 24 hours to maintain proper dosing

Always consult with a healthcare provider or pharmacist before altering any medication’s form or administration method.

Alternatives to Crushing Metoprolol

When crushing metoprolol is not an option, what alternatives are available? Healthcare providers may consider several approaches:

1. Liquid formulations:
   • Some pharmacies can compound liquid metoprolol
   • Commercially available oral solutions may exist in some regions
2. Alternative beta-blockers:
   • Other beta-blockers may be available in liquid or crushable forms
   • A different medication within the same class might be suitable
3. Different administration routes:
   • In some cases, injectable forms of beta-blockers may be considered for short-term use
   • Transdermal patches containing beta-blockers are available for certain indications

The choice of alternative depends on the patient’s specific medical needs, the reason for requiring a non-oral form, and the duration of therapy.

The Role of Healthcare Providers in Metoprolol Administration

Healthcare providers play a crucial role in ensuring the safe and effective use of metoprolol. How can they best support patients in proper medication administration?

• Educate patients on the differences between metoprolol formulations
• Provide clear instructions on whether their specific prescription can be crushed or split
• Offer guidance on alternative administration methods when necessary
• Monitor patients for adherence and efficacy, especially when changing formulations or administration methods
• Collaborate with pharmacists to address complex administration scenarios

Pharmacist Consultation

Pharmacists are invaluable resources when it comes to medication administration. They can:

• Provide detailed information on proper medication handling
• Suggest alternative formulations or medications when crushing is not an option
• Compound specialized formulations when commercially available options are unsuitable
• Offer guidance on drug interactions and potential side effects

Patients should be encouraged to consult their pharmacist whenever they have questions about their medications, including metoprolol administration.

Metoprolol in the Context of Cardiovascular Health

Understanding the importance of proper metoprolol administration is crucial in the broader context of cardiovascular health. How does metoprolol contribute to heart health, and why is correct administration so important?

Metoprolol’s Mechanism of Action

Metoprolol belongs to a class of medications known as beta-blockers. It works by:

• Blocking the effects of the hormone epinephrine (adrenaline)
• Slowing heart rate
• Reducing blood pressure
• Decreasing the heart’s workload

These effects make metoprolol valuable in treating various cardiovascular conditions, including hypertension, angina, and heart failure.

Importance of Consistent Blood Levels

The extended-release formulation of metoprolol (succinate) is designed to maintain consistent blood levels of the medication throughout the day. This consistent level is crucial for:

• Maintaining stable blood pressure control
• Reducing the risk of cardiovascular events
• Minimizing side effects associated with peak and trough levels

Crushing extended-release metoprolol disrupts this carefully designed release pattern, potentially compromising its therapeutic benefits.

Adherence and Cardiovascular Outcomes

Proper administration of metoprolol is closely tied to medication adherence, which is crucial for optimal cardiovascular outcomes. How does adherence impact heart health?

• Consistent use of metoprolol as prescribed leads to better blood pressure control
• Proper adherence reduces the risk of heart attacks, strokes, and other cardiovascular events
• Regular use helps maintain the medication’s protective effects on the heart

By ensuring patients understand how to take their metoprolol correctly, healthcare providers can promote better adherence and, consequently, improved cardiovascular health.

Future Developments in Metoprolol Formulations

As pharmaceutical technology advances, new formulations of metoprolol and other beta-blockers may emerge. What potential developments might we see in the future?

Novel Delivery Systems

• Transdermal patches: Providing steady drug release through the skin
• Nasal sprays: Offering rapid absorption for acute situations
• Long-acting injectable formulations: Potentially improving adherence for some patients

Improved Extended-Release Technologies

Future extended-release formulations might offer:

• Even more consistent drug release patterns
• Formulations that can be crushed without losing extended-release properties
• Customizable release profiles to match individual patient needs

Personalized Medicine Approaches

Advances in pharmacogenomics may lead to:

• Tailored metoprolol formulations based on individual genetic profiles
• Dosing regimens optimized for specific patient populations
• Combination products that address multiple cardiovascular risk factors

As these developments unfold, it will be crucial for healthcare providers to stay informed and adapt their prescribing and counseling practices accordingly.

Patient Education: Key to Safe Metoprolol Use

Empowering patients with knowledge about their medications is essential for safe and effective use. What key points should be included in patient education about metoprolol?

Understanding the Medication

• Explain the difference between immediate-release and extended-release formulations
• Clarify why certain forms can be crushed or split while others cannot
• Discuss the importance of taking metoprolol as prescribed

Proper Administration Techniques

• Provide clear instructions on how to take the specific formulation prescribed
• Demonstrate proper tablet splitting techniques if applicable
• Explain what to do if a dose is missed

Monitoring and Side Effects

• Teach patients how to monitor their blood pressure at home
• Discuss potential side effects and when to seek medical attention
• Emphasize the importance of regular follow-up appointments

Lifestyle Considerations

• Discuss potential interactions with other medications, including over-the-counter drugs
• Advise on dietary considerations, such as consistent sodium intake
• Explain the importance of maintaining a healthy lifestyle alongside medication use

By providing comprehensive education, healthcare providers can help ensure that patients use metoprolol safely and effectively, maximizing its cardiovascular benefits while minimizing risks.

Can You Crush Metoprolol? | HelloPharmacist

Key points

• There are two different forms of metoprolol available, metoprolol succinate and metoprolol tartrate.
• Metoprolol tartrate can be crushed while metoprolol succinate (an extended-release product) cannot.

Hello and thanks for reaching out!

The answer to this depends on which form of metoprolol you are talking about, as it is available as:

• Metoprolol tartrate
• Metoprolol succinate

Metoprolol tartrate is an immediate-release version of the drug while metoprolol succinate is the extended-release version.

Which Can You Crush?

Metoprolol tartrate (generic for Lopressor) can safely be crushed. Doing so will not alter how the medication works

Metoprolol succinate (generic for Toprol XL) on the other hand, cannot be crushed as it is an extended-release product. Doing so will destroy the extended-release mechanism, causing all of the medication to be released at once.

Interesting enough, metoprolol succinate can be split and is scored (i.e. has a break line in the middle of the tablet). This is uncommon among extended-release drugs and metoprolol succinate is one of the few extended-release drugs where splitting is okay.

Metoprolol succinate can be split due to how the extended-release mechanism works. Each tablet contains contains a number of small controlled release pellets, which are evenly dispersed throughout the tablet. This can be seen in the image below.

Each pellet acts as their own delivery device, and splitting the tablets will not destroy them. For this reason, the tablet can be split. However, as mentioned, the tablets cannot be crushed, as doing so will destroy these pellets.

Final Words

Thanks again for your question!

I hope this answer helped.

Please feel free to reach out to us again in the future.

References

• 
  Metoprolol Monograph,
  PubChem
  
• 
  Toprol XL prescribing Information,
  AccessFDA
  
• 
  Lopressor Prescribing Information,
  AccessFDA
  

To Crush or Not to Crush

There are multiple reasons for crushing tablets or capsule contents before administering medications, but there are numerous medications that should not be crushed. These medications should not be chewed, either, usually due to their specific formulations and their pharmacokinetic properties.1 Most of the no-crush medications are sustained-release, oral-dosage formulas. The majority of extended-release products should not be crushed or chewed, although there are some newer slow-release tablet formulations available that are scored and can be divided or halved (e.g., Toprol XL).

A common reason for crushing a tablet or capsule is for use by a hospitalized patient with an enteral feeding tube. A recent review in the American Journal of Health-System Pharmacy provides more details about administering medications in patients with enteral feeding tubes.2 Oral solutions can be used when commercially available and medically appropriate. If an oral solution or suspension is not available, the hospital pharmacy should be consulted to determine if a liquid formulation of the product can be extemporaneously prepared. In some cases, after careful consideration of compatibility, stability, and drug absorption changes, an injectable formulation of a product may be used. You should always consult your hospital pharmacist for information on this modality of drug administration.

Some patients have difficulty swallowing tablets or capsules; some dislike the taste. In these cases, crushing of medication for powdered delivery (to be mixed with food or beverages) should be considered. But beware of certain caveats, as not all medications are suitable for crushing. Generally, meds that should not be crushed fall into one of these categories:

• Sustained-release tablets, which can be composed of multiple layers for different drug release times, as can beads within capsules. Some of the more common prefixes or suffixes for sustained-release, controlled-release, or controlled-delivery products include: 12-hour, 24-hour, CC, CD, CR, ER, LA, Retard, SA, Slo-, SR, XL, XR, or XT.
• Enteric-coated tablets, which are formulated because certain drugs can be irritating to the stomach or are degraded by stomach acid. By enteric-coating tablets or capsule beads, the drug’s release can be delayed until it reaches the small intestine. Prefixes include EN- and EC-.

Other medications have objectionable tastes and are sugar-coated to improve tolerability. If this type of medication is crushed, the patient would be subject to its unpleasant taste, which could significantly impair medication adherence. Additionally, both sublingual and effervescent medications should not be crushed because it will decrease the medication’s effectiveness.

Hospital Pharmacy publishes a wall chart that includes many of these types of formulations, along with their do’s and don’ts. If there is ever any doubt about the best way to administer a particular product or whether it can be halved or crushed, ask your pharmacist.3 TH

Michele B. Kaufman, PharmD, BSc, RPh, is a freelance medical writer based in New York City.

New Generics

• Stavudine capsules (generic Zerit)4

New Drugs, Indications & Dosage Forms

Cinryze, a C1 esterase inhibitor (human), is FDA-approved as a new orphan drug for routine prophylaxis against angioedema in patients with hereditary angioedema (HAE). 5 The drug is administered intravenously (IV) and can be administered every three to four days for routine HAE attack prevention, which can spontaneously occur during stress, surgery, or infection, and lead to rapid swelling of the hands, feet, limbs, face, intestinal tract, or airway.6

Granisetron 3.1mg/24-hour transdermal patch (Sancuso) is FDA-approved for preventing nausea and vomiting in adults receiving moderate or high-chemotherapy regimens for up to five consecutive days.7 To dose the patch, apply it to a clean, dry area of intact healthy skin on the upper outer arm 24 to 48 hours before chemotherapy, and remove it at least 24 hours after chemotherapy has been completed. A patch may be worn for up to seven days. They should not be cut.

Hydrocodone bitartrate 10-mg/chlorpheniramine 8-mg (Tussicaps) is FDA-approved as a Schedule III controlled substance as an antitussive/antihistamine combination.8 Adult dosage is one capsule every 12 hours.

Lacosamide (Vimpat) is FDA-approved for add-on therapy in patients ≥17 years with uncontrolled, partial-onset seizures. 11 The starting dose is 50 mg twice daily and may be increased to a daily dose of 200-400 mg as two divided doses. The most common adverse reactions in clinical trials were diplopia, headache, dizziness, and nausea. Both the oral tablets and the IV infusion are bioequivalent.

Mesalamine extended-release 0.375-gm capsules (Apriso) is FDA-approved for once-daily dosing for the maintenance of remission of ulcerative colitis.9 Mesalamine is a local-acting aminosalicylate. The recommended dose is four capsules (1.5 g/day) in the morning with or without food. Because release of the active drug is pH-dependent, it should not be administered with antacids.

Ranolazine (Ranexa) is FDA-approved as an initial treatment for chronic angina.10 It can be used as monotherapy, in combination with beta blockers, or with other drugs.

Quetiapine extended-release tablets (Seroquel XR) are FDA-approved to treat depressive episodes in bipolar disorder, manic and mixed episodes in bipolar I disorder, and the maintenance treatment of bipolar I disorder as adjunct therapy to lithium or divalproex.